BSE filing, NSE: ICRA. Summary written from the filing by ALFA Finder's alert engine.
ICRA Ltd: key numbers
- Share price
- ₹4,475.00
- Market cap
- ₹4,319 Cr
- Revenue (annual)
- ₹599.5 Cr
- Net profit (annual)
- ₹181.5 Cr
- P/E (TTM)
- 22.1×Sector 19.7×
- Promoter holding
- 51.87%+0.00% QoQ
- FII holding
- 8.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICRA Ltd
All →ICRA Board Meeting Date
ICRA Limited has scheduled a board meeting on October 29, 2026, to consider and approve the company's unaudited standalone and consolidated financial results.
ICRA Management Change
ICRA appointed Mr. Ritesh Gupta as Executive Vice President & Chief Business Officer-Designate, effective October 12, 2026. He succeeds Mr. L. Shivakumar, who retires December 31, 2026.
ICRA Other Announcement
The Adivam Family Trust, a connected person, sold 500 equity shares of ICRA Ltd in a market sale transaction. The total value of the sale is Rs.0.24 Crore.
- Value
- ₹0.24 Cr
ICRA Employee Stock Options
KMP Venkatesh Viswanathan acquired 206 equity shares of ICRA Ltd valued at ₹0.10 Crore through an ESOP exercise. The transaction occurred on August 31, 2026.
- Value
- ₹0.10 Cr
ICRA Employee Stock Options
KMP Amit Gupta acquired 346 shares of ICRA Ltd valued at approximately Rs. 0.17 Crore through an ESOP exercise. This insider trading disclosure reports the transaction.
- Value
- ₹0.17 Cr
ICRA Other Announcement
ICRA Limited published a notice in newspapers regarding a special window for the transfer and dematerialisation of physical securities. This filing is for shareholder information.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.